rethinkPeptides Search
Menu
Study breakdown

GH Secretagogue Receptors Found in Human Pituitary Tumors

In VitroPreliminary evidence
The takeaway

The growth hormone secretagogue receptor (GHS-R) is expressed in human pituitary tumors and rat GH3 cells, suggesting these tumors retain responsiveness to GHRPs.

GHS-R 1a + 1b detected

Both active and inactive receptor isoforms found in human pituitary adenomas via RT-PCR

What the researchers found

GHS-R type 1a (active) and type 1b (inactive) mRNA was detected in human pituitary tumor tissue and rat GH3 cells via RT-PCR, confirming these tumors express the GHRP receptor.

Why it matters

The presence of functional GHRP receptors in pituitary tumors has clinical implications: GHRP stimulation tests could help diagnose pituitary adenomas, and understanding receptor expression patterns may reveal how these tumors maintain or lose normal regulatory controls.

How the study worked

RT-PCR analysis of GHS-R mRNA expression in surgically removed human pituitary adenomas and rat GH3 cell lines, with comparison of type 1a vs. 1b receptor isoform expression.

What this study cannot tell us

mRNA detection doesn't confirm functional protein expression. Limited number of tumor samples. Tumor heterogeneity means not all pituitary adenomas may show the same receptor profile.

How to read the evidence

Molecular biology study with appropriate methodology. Demonstrates receptor presence but not functional significance. Published in a top endocrinology journal.

When this study was published

Published in 1998, shortly after the GHS-R was cloned. Foundational for understanding GHRP receptor distribution in pituitary disease.

The bigger picture

This finding connects GH secretagogue biology to clinical endocrinology. Pituitary tumors are relatively common, and knowing they retain GHS-R expression helps explain why patients with these tumors often respond to GHRP stimulation tests — a tool used in clinical diagnosis of pituitary disorders.

Questions still open

  • Does GHS-R expression level correlate with tumor aggressiveness or GH hypersecretion?
  • Could GHS-R be a therapeutic target in pituitary adenomas?
  • Do non-functioning pituitary adenomas also express GHS-R?

Common questions

What is the GH secretagogue receptor?
The GHS-R is a receptor in the brain and pituitary gland that responds to growth hormone-releasing peptides (GHRPs). When activated, it triggers growth hormone release. It's also the receptor for ghrelin.
Why does it matter that pituitary tumors have this receptor?
It means these tumors can still respond to GHRP stimulation, which is useful for diagnostic testing. It also raises questions about whether the receptor plays a role in tumor growth or hormone overproduction.

Read the original research

Presence of growth hormone secretagogue receptor messenger ribonucleic acid in human pituitary tumors and rat GH3 cells.

The Journal of clinical endocrinology and metabolism, 83(2), 638-42

Citation

Adams, E F; Huang, B; Buchfelder, M; Howard, A; Smith, R G; Feighner, S D; van der Ploeg, L H; Bowers, C Y; Fahlbusch, R. (1998). Presence of growth hormone secretagogue receptor messenger ribonucleic acid in human pituitary tumors and rat GH3 cells.. The Journal of clinical endocrinology and metabolism, 83(2), 638-42.